AxoGen Company Profile (NASDAQ:AXGN)

About AxoGen (NASDAQ:AXGN)

AxoGen logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Symbol: NASDAQ:AXGN
  • CUSIP: N/A
  • Web:
  • Market Cap: $541.11 million
  • Outstanding Shares: 33,095,000
Average Prices:
  • 50 Day Moving Avg: $15.83
  • 200 Day Moving Avg: $12.51
  • 52 Week Range: $6.45 - $17.25
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -232.14
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $45.24 million
  • Price / Sales: 11.89
  • Book Value: $0.37 per share
  • Price / Book: 43.92
  • EBIDTA: ($8,230,000.00)
  • Net Margins: -32.05%
  • Return on Equity: -155.78%
  • Return on Assets: -31.67%
  • Debt-to-Equity Ratio: 1.67%
  • Current Ratio: 3.83%
  • Quick Ratio: 3.28%
  • Average Volume: 209,933 shs.
  • Beta: 0.27
  • Short Ratio: 6.09
Frequently Asked Questions for AxoGen (NASDAQ:AXGN)

What is AxoGen's stock symbol?

AxoGen trades on the NASDAQ under the ticker symbol "AXGN."

How were AxoGen's earnings last quarter?

AxoGen, Inc. (NASDAQ:AXGN) announced its quarterly earnings data on Thursday, May, 4th. The company reported ($0.11) EPS for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.01. The firm earned $12.24 million during the quarter, compared to the consensus estimate of $11.83 million. AxoGen had a negative return on equity of 155.78% and a negative net margin of 32.05%. View AxoGen's Earnings History.

When will AxoGen make its next earnings announcement?

AxoGen is scheduled to release their next quarterly earnings announcement on Wednesday, August, 2nd 2017. View Earnings Estimates for AxoGen.

Where is AxoGen's stock going? Where will AxoGen's stock price be in 2017?

5 equities research analysts have issued 12-month target prices for AxoGen's stock. Their predictions range from $11.00 to $18.00. On average, they expect AxoGen's share price to reach $14.38 in the next year. View Analyst Ratings for AxoGen.

Who are some of AxoGen's key competitors?

Who owns AxoGen stock?

AxoGen's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Russell Investments Group Ltd. (1.85%), Perkins Capital Management Inc. (1.68%), Pennsylvania Trust Co (0.17%), Campbell & CO Investment Adviser LLC (0.06%) and Bank of Montreal Can (0.05%). Company insiders that own AxoGen stock include Amy Mcbride Wendell, James E Flynn, John P Engels, Joseph M Mandato, Karen L Zaderej and Peter J Mariani. View Institutional Ownership Trends for AxoGen.

Who sold AxoGen stock? Who is selling AxoGen stock?

AxoGen's stock was sold by a variety of institutional investors in the last quarter, including Pennsylvania Trust Co and Perkins Capital Management Inc.. View Insider Buying and Selling for AxoGen.

Who bought AxoGen stock? Who is buying AxoGen stock?

AxoGen's stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd. and Campbell & CO Investment Adviser LLC. Company insiders that have bought AxoGen stock in the last two years include Amy Mcbride Wendell, John P Engels, Karen L Zaderej and Peter J Mariani. View Insider Buying and Selling for AxoGen.

How do I buy AxoGen stock?

Shares of AxoGen can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AxoGen's stock price today?

One share of AxoGen stock can currently be purchased for approximately $16.25.

MarketBeat Community Rating for AxoGen (NASDAQ AXGN)
Community Ranking:  3.5 out of 5 (   )
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  29 (Vote Underperform)
Total Votes:  98
MarketBeat's community ratings are surveys of what our community members think about AxoGen and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for AxoGen (NASDAQ:AXGN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.38 (11.54% downside)

Analysts' Ratings History for AxoGen (NASDAQ:AXGN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/29/2017Cantor FitzgeraldInitiated CoverageOverweight -> Overweight$18.00HighView Rating Details
5/19/2017WedbushReiterated RatingOutperform$17.00 -> $14.00HighView Rating Details
3/6/2017Roth CapitalInitiated CoverageBuy -> Buy$14.50N/AView Rating Details
11/22/2016JMP SecuritiesReiterated RatingBuyN/AView Rating Details
11/22/2016Lake Street CapitalUpgradeHold -> Buy$9.00 -> $11.00N/AView Rating Details
(Data available from 7/27/2015 forward)


Earnings History for AxoGen (NASDAQ:AXGN)
Earnings by Quarter for AxoGen (NASDAQ:AXGN)
Earnings History by Quarter for AxoGen (NASDAQ AXGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2017($0.08)N/AView Earnings Details
5/4/2017Q1 2017($0.10)($0.11)$11.83 million$12.24 millionViewListenView Earnings Details
2/22/2017Q4 2016($0.09)($0.10)$11.41 millionViewListenView Earnings Details
11/2/2016Q3 2016($0.08)($0.08)$11.21 million$11.21 millionViewN/AView Earnings Details
8/3/2016Q2($0.12)($0.09)$9.28 million$10.38 millionViewN/AView Earnings Details
11/5/2015Q3 2015($0.12)($0.11)$6.70 million$8.15 millionViewN/AView Earnings Details
8/6/2015Q2 2015($0.15)($0.13)$5.89 million$6.42 millionViewN/AView Earnings Details
5/5/2015Q1 2015($0.17)($0.16)$4.90 million$4.95 millionViewN/AView Earnings Details
11/13/2014Q3 2014($0.24)($0.19)$4.67 millionViewN/AView Earnings Details
8/4/2014Q2 2014($0.22)($0.21)$3.30 million$4.21 millionViewN/AView Earnings Details
4/30/2014Q1 2014($0.26)($0.24)$2.75 million$3.14 millionViewN/AView Earnings Details
3/6/2014($0.22)($0.24)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for AxoGen (NASDAQ:AXGN)
2017 EPS Consensus Estimate: ($0.25)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173($0.12)($0.07)($0.10)
Q2 20173($0.06)($0.04)($0.05)
Q3 20173($0.05)($0.03)($0.04)
Q4 20173($0.09)($0.04)($0.06)
Q1 20181$0.01$0.01$0.01
Q2 20181$0.03$0.03$0.03
Q3 20181$0.04$0.04$0.04
(Data provided by Zacks Investment Research)


Dividend History for AxoGen (NASDAQ:AXGN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for AxoGen (NASDAQ:AXGN)
Insider Ownership Percentage: 9.33%
Institutional Ownership Percentage: 63.49%
Insider Trades by Quarter for AxoGen (NASDAQ:AXGN)
Institutional Ownership by Quarter for AxoGen (NASDAQ:AXGN)
Insider Trades by Quarter for AxoGen (NASDAQ:AXGN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/7/2016Amy Mcbride WendellDirectorBuy13,333$7.50$99,997.50View SEC Filing  
10/7/2016John P EngelsVPBuy4,000$7.50$30,000.00View SEC Filing  
10/7/2016Karen L ZaderejCEOBuy10,000$7.50$75,000.00View SEC Filing  
10/7/2016Peter J MarianiCFOBuy3,333$7.50$24,997.50View SEC Filing  
8/9/2016Joseph M MandatoDirectorSell149,618$8.54$1,277,737.72View SEC Filing  
8/8/2016Joseph M MandatoDirectorSell107,450$8.63$927,293.50View SEC Filing  
7/21/2016James E FlynnInsiderSell102,136$6.70$684,311.20View SEC Filing  
7/18/2016James E FlynnInsiderSell279,303$7.53$2,103,151.59View SEC Filing  
9/18/2015James E FlynnInsiderSell345,000$5.50$1,897,500.00View SEC Filing  
6/3/2015Joseph M MandatoDirectorBuy6,500$3.10$20,150.00View SEC Filing  
6/2/2015Lee Robert Johnston JrInsiderBuy5,000$3.06$15,300.00View SEC Filing  
4/8/2015James E FlynnInsiderSell144,385$3.25$469,251.25View SEC Filing  
12/10/2014Lee Robert Johnston JrCFOBuy10,000$3.06$30,600.00View SEC Filing  
8/12/2014Mark Stephen GoldDirectorBuy20,000$2.29$45,800.00View SEC Filing  
8/8/2014Mark Stephen GoldDirectorBuy11,000$2.31$25,410.00View SEC Filing  
6/6/2014Lee Robert Johnston JrCFOBuy10,000$2.58$25,800.00View SEC Filing  
6/3/2014Gregory Gene FreitagCFOBuy5,200$2.45$12,740.00View SEC Filing  
6/3/2014Karen L ZaderejCEOBuy5,000$2.43$12,150.00View SEC Filing  
5/20/2014Jill F SchiaparelliSVPBuy2,000$2.63$5,260.00View SEC Filing  
5/12/2014Karen L ZaderejCEOBuy5,000$2.70$13,500.00View SEC Filing  
5/7/2014Mark Stephen GoldDirectorBuy1,977$2.60$5,140.20View SEC Filing  
3/13/2014Karen L ZaderejCEOBuy1,500$3.49$5,235.00View SEC Filing  
8/29/2013Shawn F MccarreySVPBuy25,000$3.21$80,250.00View SEC Filing  
8/24/2013Shawn F MccarreySVPBuy5,000$3.00$15,000.00View SEC Filing  
8/14/2013Jill F SchiaparelliSVPBuy5,000$3.00$15,000.00View SEC Filing  
8/14/2013John Frederick HarperDirectorBuy66,666$3.00$199,998.00View SEC Filing  
8/14/2013Karen L ZaderejCEOBuy8,334$3.00$25,002.00View SEC Filing  
12/4/2012Jill F SchiaparelliSVPBuy2,000$2.55$5,100.00View SEC Filing  
11/29/2012Jill F SchiaparelliSVPBuy1,000$2.70$2,700.00View SEC Filing  
11/15/2012Jill F SchiaparelliSVPBuy2,750$2.56$7,040.00View SEC Filing  
10/1/2012John Frederick HarperDirectorBuy86,557$3.61$312,470.77View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for AxoGen (NASDAQ:AXGN)
Latest Headlines for AxoGen (NASDAQ:AXGN)
DateHeadline logoAxoGen, Inc. (AXGN) Set to Announce Quarterly Earnings on Wednesday - July 26 at 7:56 AM logoAxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Buy" by Brokerages - July 25 at 8:24 AM logoZacks: Brokerages Anticipate AxoGen, Inc. (NASDAQ:AXGN) Will Post Quarterly Sales of $14.40 Million - July 22 at 8:00 AM logo Analysts Anticipate AxoGen, Inc. (NASDAQ:AXGN) to Post -$0.08 EPS - July 20 at 10:18 PM logoAxoGen, Inc. Discloses Terms of Recent Equity Award - July 20 at 5:44 PM logoGlobus Medical (GMED) & AxoGen (NASDAQ:AXGN) Critical Review - July 20 at 5:21 PM logoAxoGen, Inc. to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, - July 19 at 5:29 PM logoAxoGen, Inc. to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, August 2, 2017 - July 19 at 5:29 PM logoInteger Holdings (ITGR) & AxoGen (NASDAQ:AXGN) Head to Head Analysis - July 16 at 12:26 PM logoComparing Sunshine Heart (SSH) & AxoGen (NASDAQ:AXGN) - July 16 at 12:28 AM logoReviewing Sunshine Heart (SSH) and AxoGen (NASDAQ:AXGN) - July 15 at 10:04 PM logoReviewing Globus Medical (GMED) and AxoGen (NASDAQ:AXGN) - July 15 at 8:07 AM logoAxoGen, Inc. (NASDAQ:AXGN) Forecasted to Earn FY2017 Earnings of ($0.30) Per Share - July 6 at 9:38 AM logoAxoGen, Inc. (AXGN) Receives Consensus Rating of "Buy" from Analysts - June 29 at 6:40 PM logoAxoGen, Inc. (AXGN) Receives New Coverage from Analysts at Cantor Fitzgerald - June 29 at 6:02 PM logoAxoGen (AXGN) & Integer Holdings (ITGR) Head to Head Review - June 29 at 8:05 AM logo$14.40 Million in Sales Expected for AxoGen, Inc. (AXGN) This Quarter - June 28 at 10:34 AM logoAxoGen, Inc. (AXGN) Expected to Announce Earnings of -$0.08 Per Share - June 26 at 6:38 PM logoAxoGen (AXGN) Presents at JMP Securities Life Sciences Conference 2017 - Slideshow - June 22 at 3:52 PM logoAxoGen, Inc. (AXGN) Rating Increased to Hold at ValuEngine - June 12 at 10:58 PM logoETFs with exposure to AxoGen, Inc. : June 8, 2017 - June 8 at 4:29 PM logoAxoGen, Inc. to Present at the JMP Securities Life Sciences Conference - June 7 at 7:41 AM logoAxoGen, Inc. (AXGN) - June 5 at 12:59 PM logoZacks: Brokerages Expect AxoGen, Inc. (AXGN) Will Announce Quarterly Sales of $14.40 Million - June 2 at 1:16 PM logo-$0.07 EPS Expected for AxoGen, Inc. (AXGN) This Quarter - May 31 at 2:26 PM logoAxoGen's (AXGN) CEO Karen Zaderej Hosts 2017 Annual Shareholders' Meeting (Transcript) - May 25 at 2:08 AM logoAxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session - May 22 at 10:08 AM logoAxoGen (AXGN): Management Meeting Highlights New Opportunity - Wedbush - May 19 at 9:21 AM logoWedbush Reaffirms Outperform Rating for AxoGen, Inc. (AXGN) - May 19 at 7:42 AM logoETFs with exposure to AxoGen, Inc. : May 15, 2017 - May 15 at 4:16 PM logoAxoGen, Inc. :AXGN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 - May 10 at 3:58 PM logoFY2019 EPS Estimates for AxoGen, Inc. Raised by Wedbush (AXGN) - May 8 at 12:12 PM logoAxoGen, Inc. (AXGN) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS - May 5 at 3:58 PM logoZacks: Brokerages Anticipate AxoGen, Inc. (AXGN) to Announce -$0.05 EPS - May 5 at 2:25 PM logoAxoGen, Inc. Reports 2017 First Quarter Financial Results - May 4 at 8:55 PM logoAxoGen reports 1Q loss - May 4 at 8:55 PM logoInvestor Network: AxoGen, Inc. to Host Earnings Call - May 4 at 3:53 PM logoETFs with exposure to AxoGen, Inc. : May 2, 2017 - May 3 at 11:52 AM logoSomewhat Negative News Coverage Very Likely to Affect AxoGen (AXGN) Stock Price - May 2 at 6:10 PM logoAxoGen, Inc. (AXGN) Set to Announce Earnings on Thursday - May 2 at 10:24 AM logoSomewhat Negative News Coverage Extremely Likely to Affect AxoGen (AXGN) Stock Price - April 29 at 11:14 AM logoAxoGen (AXGN) Given News Sentiment Rating of 0.56 - April 24 at 1:00 PM logoSomewhat Positive Press Coverage Very Likely to Affect AxoGen (AXGN) Stock Price - April 21 at 11:39 AM logoAxoGen (AXGN) Earning Somewhat Positive Media Coverage, AlphaOne Reports - April 18 at 12:20 PM logoETFs with exposure to AxoGen, Inc. : April 17, 2017 - April 17 at 3:42 PM logoAxoGen, Inc. (AXGN) Short Interest Up 2.0% in March - April 17 at 10:48 AM logoAxoGen, Inc. (AXGN) Expected to Post Quarterly Sales of $11.83 Million - April 16 at 8:38 AM logoAxoGen (AXGN) Receiving Favorable Media Coverage, Report Shows - April 15 at 10:55 AM logoAxoGen, Inc. (AXGN) Expected to Announce Earnings of -$0.10 Per Share - April 14 at 4:32 PM logoAxoGen, Inc. to Report First Quarter 2017 Financial Results and Host Conference Call on Thursday, May 4, 2017 - April 14 at 11:19 AM



AxoGen (AXGN) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by Staff